Putative probiotic Lactobacillus spp. from porcine gastrointestinal tract inhibit transmissible gastroenteritis coronavirus and enteric bacterial pathogens

Abstract

A total of 310 bacterial strains isolated from the porcine gastrointestinal tract were tested for their activity against transmissible gastroenteritis (TGE) coronavirus and other enteric pathogens. Based on activity, the strains Probio-38 and Probio-37 were selected as potential probiotics and identified as Lactobacillus plantarum Probio-38 and Lactobacillus salivarius Probio-37 respectively by 16S rRNA gene sequencing. Supernatants of these strains inhibited TGE coronavirus in vitro in ST cells, without any cytopathic effect even after 72 h of incubation. Both the strains exhibited high survival in synthetic gastric juice. The strains were resistant to 5% porcine bile and exhibited antimicrobial activity against all the 13 enteric bacterial pathogens tested. These strains also exhibited resistance to most of the antibiotics analyzed. The inhibition of transmissible gastroenteritis coronavirus and enteric bacterial pathogens as well as the bile tolerance, high survival in gastric juice, and the antibiotic resistance indicate that the two isolated bacterial strains are ideal probiotic candidates for animal application after proper in vivo experiments.

Characterization of Lactic Acid Bacteria Isolated From the Gastrointestinal Tract of a Wild Boar as Potential Probiotics

“…A large amount of evidences suggest that certain probiotic strains can confer the ability of anti-infection with intestinal pathogenic microbes (57)(58)(59). As more and more concerns have been paid to the prevalence of antibiotic resistance, the antibacterial activity against pathogenic bacteria has attracted extensive attention (60).…”

Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic

“…Evidence for antiviral activity of probiotic strains against common respiratory viruses, including influenza, rhinovirus, and respiratory syncytial virus comes from clinical and experimental studies (17)(18)(19)41). While none of these effects or mechanisms have been tested on the new SARS-CoV-2 virus, this should not negate considering this approach, especially when effects of probiotics against other coronavirus strains have been reported (42)(43)(44)(45). Furthermore, patients are dying from secondary bacterial infections.…”

Probiotics in the prophylaxis of COVID-19: something is better than nothing

“…The use of L. plantarum, L. salivarius, L. rhamnosus GG, and L. casei Shirota is well reported for their antiviral activity against rotavirus, transmissible gastroenteritis coronavirus (Maragkoudakis et al 2010;Rejish Kumar et al 2010). Furthermore, the in vitro antiviral activity of probiotic strain Enterococcus faecium NCIMB 10,415 demonstrated the 3-log reduction in the viral titer.…”